YOLFTbeta
NA

Namwiwat Medical

NAM · BK · Healthcare / Medical Devices

3.08THB-0.10 (-3.14%)

Price History

Full chart

Market Stats

Previous Close3.18
Open3.12
Day Range3.08 – 3.14
52-Week Range3.02 – 3.94
Volume4.80K
Market Cap2.24B
P/E (TTM)26.67
Forward P/E0.00
EPS0.12
Dividend Yield4.09%
Beta0.21
50-Day Avg3.29
200-Day Avg3.54

About

Namwiwat Medical Corporation Public Company Limited manufactures and distributes medical equipment in Thailand. The company offers steam and low temperature sterilizers, instrument washer disinfectors, ultrasonic cleaning systems, and drying cabinets, as well as waste sterilizers. It also provides NAMTrack, a central sterile supply department software management product, as well as Air Track. In addition, the company offers air and surface disinfection equipment and air purifiers. Further, it provides medical supplies, disinfection services, medical equipment maintenance services, infectious waste services, and other medical services. The company was founded in 1970 and is based in Samut Prakan, Thailand.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Viroj Chaiturdkiet
  • Employees0
  • Headquarters999/3-5 Moo 9, Samut Prakan, Thailand, 10290, Thailand
  • Websitehttps://www.namwiwat.com

Leadership

  • Mr. Winai PhattiyakulIndependent Chairman of the Board
  • Mr. Viroj ChaiturdkietCEO, Acting Chief Officer Sales and Marketing & Director
  • Mr. Sukhum PhothisawatChief Accounting & Finance Officer
  • Mr. Wisit ChaiturdkietCOO & Director
  • Ms. Nantira ChaiturdkietChief Business Support Officer & Director
  • Mr. Pongchet KongsakDeputy Chief Executive Officer
  • Mr. Wichai ChaiterdkiatDeputy Chief Executive Officer

Financials

Income Statement

Currency: THB2022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue992.15M1.10B1.10B1.11B1.87B
Growth (%)-+10.81%+0.13%+1.24%+67.79%
Cost of Revenue591.59M696.29M620.70M646.51M1.33B
Gross Profit400.56M403.08M480.05M467.87M540.57M
Gross Margin40.37%36.66%43.61%41.99%28.91%
Operating Expense170.14M180.01M230.16M255.54M384.68M
Operating Income230.42M223.06M249.90M212.33M155.90M
Operating Margin23.22%20.29%22.70%19.05%8.34%
EBITDA-256.21M295.64M282.45M244.24M
EBITDA Margin-23.30%26.86%25.35%13.06%
Net Income174.65M175.71M200.75M180.87M101.59M
Net Income Margin17.60%15.98%18.24%16.23%5.43%
Interest Expense14.03M12.99M15.73M12.68M23.33M
Interest Expense % of Total Revenue1.41%1.18%1.43%1.14%1.25%

Balance Sheet

Currency: THB2021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets823.40M1.06B1.70B2.35B2.71B3.05B
Total Liabilities563.80M621.07M487.03M386.93M613.62M949.40M
Total Equity259.61M434.12M1.21B1.96B2.07B2.00B
Cash24.02M40.64M59.02M995.66M920.84M697.82M
Net Debt395.73M360.16M189.66M---

Cash Flow

Currency: THB2022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow97.82M-81.16M258.68M22.94M37.86M
Financing Cash Flow-48.93M491.58M515.67M-23.74M-170.14M
Capital Expenditure42.28M98.19M49.12M78.91M68.68M
Free Cash Flow55.54M-179.36M209.57M-55.97M-30.82M
Dividends Paid0242.50M232.05M62.99M187.00M
FCF to OCF56.78%220.98%81.01%-244.03%-81.41%
Dividend Paid to FCF0.00%-135.21%110.73%-112.53%-606.75%

Earnings

Report DateNov 14, 2023Feb 26, 2024May 14, 2024Aug 13, 2024Nov 13, 2024Mar 3, 2025May 13, 2025Aug 15, 2025Nov 17, 2025Mar 3, 2026May 20, 2026Aug 17, 2026
EPS Estimate-0.08----------
EPS Actual0.100.070.020.060.100.080.060.020.030.040.010.04
Surprise--12.50%----------
Timing-After-hours-After-hoursAfter-hoursPre-marketAfter-hours-----

Key Statistics & Ratios

Market Cap2.24B
Enterprise Value2.04B
Trailing P/E26.67
Forward P/E0.00
Price / Sales1.33
Price / Book1.12
EPS0.12
Book Value2.88
Revenue (TTM)1.69B
Gross Profit (TTM)511.72M
EBITDA164.57M
Profit Margin4.82%
Operating Margin8.83%
Return on Equity4.04%
Return on Assets2.29%
Shares Outstanding700.00M
Shares Float85.77M
Beta0.21
Dividend Yield4.09%
Dividend Rate0.13
Payout Ratio102.28%

Dividends

20261×
0.03Mar 13, 2026
20252×
0.10Nov 27, 20250.15Mar 14, 2025
20241×
0.09Mar 11, 2024